Insulin and its secretagogues activate Ca2+-dependent phosphatidylinositol breakdown and amylase secretion in rat pancreas in vitro.
We studied the effects of insulin and insulin secretagogues on pancreatic phospholipids and the release of amylase from pancreatic fragments incubated in vitro. Insulin provoked rapid, dose-related increases in amylase release, and these were accompanied by decreases in phosphatidylinositol and increases in phosphatidic acid. Glucose and other insulin secretagogues elicited similar changes in amylase release and pancreatic phospholipids; epinephrine blocked these effects of glucose, presumably via inhibition of glucose-induced insulin secretion. Effects of insulin and glucose on phospholipids and amylase release were dependent on Ca2+ in the incubation medium. These findings suggest that, in the pancreas, insulin enhances Ca2+-dependent phosphatidylinositol breakdown, which in turn influences amylase secretion. The effects of insulin on phospholipids may also explain certain other actions of insulin.
D000681:Amylases / Q000378:metabolism*; D000818:Animals; D002118:Calcium / Q000494:pharmacology*; D003513:Cycloheximide / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism / Q000494:pharmacology*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000502:physiology*; D007700:Kinetics; D008297:Male; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism*; D010712:Phosphatidic Acids / Q000378:metabolism; D010716:Phosphatidylinositols / Q000378:metabolism*; D051381:Rats
D007328:Insulin; D010712:Phosphatidic Acids; D010716:Phosphatidylinositols; D003513:Cycloheximide; D000681:Amylases; D005947:Glucose; D002118:Calcium; D004837:Epinephrine